PMC:7195088 / 32951-33152 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7195088","sourcedb":"PMC","sourceid":"7195088","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7195088","text":"• Comparison of tocilizumab vs. anakinra (recombinant IL-1 receptor antagonist) vs. siltuximab vs. anakinra plus siltuximab vs. anakinra plus tocilizumab vs. standard of care in patients with COVID-19.","divisions":[{"label":"label","span":{"begin":0,"end":1}}],"tracks":[{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T41","span":{"begin":54,"end":58},"obj":"Body_part"},{"id":"T42","span":{"begin":54,"end":56},"obj":"Body_part"}],"attributes":[{"id":"A41","pred":"fma_id","subj":"T41","obj":"http://purl.org/sig/ont/fma/fma86583"},{"id":"A42","pred":"fma_id","subj":"T42","obj":"http://purl.org/sig/ont/fma/fma86578"},{"subj":"T41","pred":"source","obj":"LitCovid-PD-FMA-UBERON"},{"subj":"T42","pred":"source","obj":"LitCovid-PD-FMA-UBERON"}]},{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T170","span":{"begin":192,"end":200},"obj":"Disease"}],"attributes":[{"id":"A170","pred":"mondo_id","subj":"T170","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"subj":"T170","pred":"source","obj":"LitCovid-PD-MONDO"}]},{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T444","span":{"begin":16,"end":27},"obj":"Chemical"},{"id":"T445","span":{"begin":54,"end":56},"obj":"Chemical"},{"id":"T447","span":{"begin":68,"end":78},"obj":"Chemical"},{"id":"T448","span":{"begin":142,"end":153},"obj":"Chemical"}],"attributes":[{"id":"A444","pred":"chebi_id","subj":"T444","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"},{"id":"A445","pred":"chebi_id","subj":"T445","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A446","pred":"chebi_id","subj":"T445","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A447","pred":"chebi_id","subj":"T447","obj":"http://purl.obolibrary.org/obo/CHEBI_48706"},{"id":"A448","pred":"chebi_id","subj":"T448","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"},{"subj":"T444","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T445","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T447","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T448","pred":"source","obj":"LitCovid-PD-CHEBI"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T264","span":{"begin":0,"end":201},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T264","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-FMA-UBERON","color":"#93b7ec","default":true},{"id":"LitCovid-PD-MONDO","color":"#d1ec93"},{"id":"LitCovid-PD-CHEBI","color":"#ec93eb"},{"id":"LitCovid-sentences","color":"#93ecd2"}]}]}}